Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-3,620
Closed -$280K 144
2016
Q2
$280K Buy
+3,620
New +$274K 0.01% 424
2016
Q1
Sell
-47,946
Closed -$3.34M 474
2015
Q4
$3.34M Buy
+47,946
New +$3.51M 0.1% 227
2015
Q3
Sell
-7,567
Closed -$601K 283
2015
Q2
$601K Sell
7,567
-55,643
-88% -$4.57M 0.01% 381
2015
Q1
$5.14M Buy
+63,210
New +$4.85M 0.09% 195
2014
Q4
Sell
-87,750
Closed -$6.42M 404
2014
Q3
$6.42M Buy
87,750
+2,580
+3% +$189K 0.05% 328
2014
Q2
$6.16M Sell
85,170
-12,499
-13% -$869K 0.04% 345
2014
Q1
$6.72M Buy
97,669
+27,200
+39% +$1.81M 0.05% 286
2013
Q4
$4.47M Sell
70,469
-3,870
-5% -$227K 0.04% 385
2013
Q3
$4.23M Buy
74,339
+17,819
+32% +$1.02M 0.04% 344
2013
Q2
$3.41M Buy
+56,520
New +$3.53M 0.04% 377

Other funds holding DVA

Euclid Advisors's DVA Position: Q3 2016 in Review

Euclid Advisors sold out of DaVita (DVA) in Q3 2016, closing a stake of 3,620 shares — an estimated $280K sold.

Euclid Advisors first reported a position in DVA in Q2 2013 and held it in 10 quarters. The position peaked at $6.72M in Q1 2014. 481 funds tracked by Wall St. Rank hold DVA as of Q3 2016.

  • Euclid Advisors reported no remaining DaVita position as of Q3 2016 after selling out during the quarter.
  • Euclid Advisors sold 3,620 DaVita shares in Q3 2016, an estimated $280K.
  • Euclid Advisors first reported a position in DaVita in Q2 2013 and held it in 10 quarters.
  • Euclid Advisors's DaVita position peaked at $6.72M in Q1 2014.
  • 481 funds tracked by Wall St. Rank held DaVita as of Q3 2016.

Based on Euclid Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.